Guidance
Recommendations for research
Recommendations for research
The guideline committee has made the following recommendations for research.
Key recommendations for research
1 Availability of PrEP
What is the effectiveness and cost effectiveness of providing pre-exposure prophylaxis (PrEP) outside sexual health services, and does this reach eligible population groups different from those who do access sexual health services?
For a short explanation of why the committee made this recommendation for research, see the rationale section on access to PrEP services .
Full details of the evidence and the committee's discussion are in evidence review G: effectiveness, cost effectiveness, acceptability and unintended consequences of PrEP for HIV.
2 Mode of PrEP delivery
What are the effectiveness, cost effectiveness, availability (eligibility status), adherence considerations, and short- and long-term adverse effects (including impact on bone density) of different modes of delivery, particularly long-acting PrEP (such as injections), including in women?
For a short explanation of why the committee made this recommendation for research, see the rationale section on prescribing PrEP .
Full details of the evidence and the committee's discussion are in evidence review G: effectiveness, cost effectiveness, acceptability and unintended consequences of PrEP for HIV.
3 Delivering effective sexual health services as part of other services
How can sexual health services best be delivered together with other services (for example, drug and alcohol services)?
For a short explanation of why the committee made this recommendation for research, see the rationale section on delivering and evaluating interventions to reduce sexually transmitted infection (STI) transmission .
Full details of the evidence and the committee's discussion are in:
4 Tailoring outreach services
How can outreach be tailored to specific groups to increase their access to sexual health services and their uptake of STI testing?
For a short explanation of why the committee made this recommendation for research, see the rationale section on meeting the needs of groups with greater sexual health or access needs .
Full details of the evidence and the committee's discussion are in:
5 Reducing stigma
What are the most effective and cost-effective methods of reducing the stigma associated with accessing sexual health services?
For a short explanation of why the committee made this recommendation for research, see the rationale and impact section on co-producing interventions to reduce STI transmission .
Full details of the evidence and the committee's discussion are in:
Other recommendations for research
6 Value of incentives
What incentives are effective and cost effective in increasing STI testing and diagnosis, and what, if any, are the adverse and unintended consequences?
For a short explanation of why the committee made this recommendation for research, see the rationale section on self-sampling to improve the uptake and increase the frequency of STI testing .
Full details of the evidence and the committee's discussion are in:
7 Vaccination course completion
What factors affect whether people complete the full course of hepatitis A and B or human papillomavirus (HPV) vaccinations and how do people think they might be encouraged to complete it?
For a short explanation of why the committee made this recommendation for research, see the rationale section on HPV and hepatitis A and B vaccination in gay, bisexual and other men who have sex with men .
Full details of the evidence and the committee's discussion are in evidence review F: increasing uptake of hepatitis A, hepatitis B and human papillomavirus (HPV) vaccinations in gay, bisexual and other men who have sex with men.
8 Eligibility for PrEP
What is the cost effectiveness of providing PrEP to people who do not report recent condomless sex?
For a short explanation of why the committee made this recommendation for research, see the rationale section on raising awareness of pre-exposure prophylaxis for HIV .
Full details of the evidence and the committee's discussion are in evidence review G: effectiveness, cost effectiveness, acceptability and unintended consequences of PrEP for HIV.
9 Remote self-sampling
Have people's attitudes to remote self-sampling and regular testing for STIs changed as a result of self-sampling for COVID‑19?
What are the effectiveness and adverse outcomes of self-sampling for people with symptoms, if remote triage (for example, phone triage) indicates that this is appropriate?
For a short explanation of why the committee made this recommendation for research, see the rationale section on self-sampling to improve the uptake and increase the frequency of STI testing .
Full details of the evidence and the committee's discussion are in:
10 Delivering effective sexual health services
What are the experiences of LGBT+ people in accessing STI testing services, including online?
For a short explanation of why the committee made this recommendation for research, see the rationale section on tailoring interventions to improve the uptake and increase the frequency of STI testing .
Full details of the evidence and the committee's discussion are in: